amifostine anhydrous has been researched along with Leukemia, Lymphocytic in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Valeriote, F | 1 |
| Grates, HE | 1 |
1 other study available for amifostine anhydrous and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Dose and interval relationship for the interaction of WR-2721 and nitrogen mustard with normal and malignant cells.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Drug Synergism; Female; Hematopoietic Stem Ce | 1984 |